Sat.Apr 12, 2025 - Fri.Apr 18, 2025

article thumbnail

FDA Eliminates Animal Testing: Impact on Biotechs

The Premier Consulting Blog

On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ 1] Instead, within 3-5 years, the expectation will be to leverage an integrated safety assessment approach, combining information from a comprehensive battery of New Approach Methodologies (NAM).

article thumbnail

Our DNA is at risk of hacking, warn scientists

Science Daily: Pharmacology News

According to new research next-generation DNA sequencing (NGS) -- the same technology which is powering the development of tailor-made medicines, cancer diagnostics, infectious disease tracking, and gene research -- could become a prime target for hackers.

DNA 360
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Substrate Trapping in Polyketide Synthase Thioesterase Domains: Structural Basis for Macrolactone Formation

Covalent Modifiers

Tyler M. McCullough, Vishakha Choudhary, David L. Akey, Meredith A. Skiba, Steffen M. Bernard, Jeffrey D. Kittendorf, Jennifer J. Schmidt, David H. Sherman, and Janet L. Smith ACS Catalysis 2024 14 (16), 12551-12563 DOI: 10.1021/acscatal.4c03637 Emerging antibiotic resistance requires continual improvement in the arsenal of antimicrobial drugs, especially the critical macrolide antibiotics.

article thumbnail

New research kindles excitement around stem cell therapies for Parkinson’s

BioPharma Drive: Drug Pricing

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also show promising — albeit unproven — signs of efficacy.

Therapies 303
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

New Antibiotic, Blujepa, May Be Effective in Treating Gonorrhea

Drugs.com

TUESDAY, April 15, 2025 — A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medication, called gepotidacin, sold under the brand name Blujepa, could become the.

Drugs 289

More Trending

article thumbnail

Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding

Covalent Modifiers

Pasquale A. Morese, Ayaz Ahmad, Mathew P. Martin, Richard A. Noble, Sara Pintar, Lan Z. Wang, Shangze Xu, Andrew Lister, Richard A. Ward, Agnieszka K. Bronowska, Martin E. M. Noble, Hannah L. Stewart & Michael J. Waring Commun Chem 8 , 111 (2025). [link] The discovery of targeted covalent inhibitors is of increasing importance in drug discovery.

Drugs 130
article thumbnail

FDA cuts outlined in draft HHS budget

BioPharma Drive: Drug Pricing

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could be in store for an agency already shaken by large-scale layoffs.

FDA 252
article thumbnail

Common Meds Appear To Delay Onset Of Parkinson's Disease

Drugs.com

THURSDAY, April 17, 2025 -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinsons disease, a new study says.Parkinsons symptoms took nearly a decade longer to crop up in patients taking the.

Disease 279
article thumbnail

Groundbreaking study uncovers how our brain learns

Science Daily: Pharmacology News

How do we learn new things? Neurobiologists using cutting-edge visualization techniques have revealed how changes across our synapses and neurons unfold. The findings depict how information is processed in our brain's circuitry, offering insights for neurological disorders and brain-like AI systems.

303
303
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Covalent Modification of Glutamic Acid Inspired by HaloTag Technology

Covalent Modifiers

Waldmann H, Zhang R, liu J, Gasper R, Janning P. ChemRxiv. 2025 doi:10.26434/chemrxiv-2025-70x40. [link] For targeted covalent protein modification at low reactivity aspartates and glutamates, new methods are in high demand. Inspired by the HaloTag technology we have developed a new technique which employs a reaction between chloroalkane-functionalised ligands and a specific glutamate residue.

147
147
article thumbnail

US launches probe that could set stage for pharma tariffs

BioPharma Drive: Drug Pricing

The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.

article thumbnail

ADHD Drugs Generally Safe For Heart Health, Review Says

Drugs.com

MONDAY, April 14, 2025 -- Worried about taking the ADHD meds youve been prescribed because they might harm your heart health?Theres no need to fret, according to a new evidence review.ADHD medications generally have just a small effect on a per.

Drugs 283
article thumbnail

Strongest hints yet of biological activity outside the solar system

Science Daily: Pharmacology News

Astronomers have detected the most promising signs yet of a possible biosignature outside the solar system, although they remain cautious.

297
297
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

CDD Vault Update (April 2025 #2): Pharmacokinetic (PK) and Michaelis-Menten Kinetics (Km/Kd) Curve Fit Equations, Donut Charts, TIFF Image Previews, and Parallel Reactions

Collaborative Drug

CDD Update March #2 2025 Full Atom Layout of Macromolecules New Dataset for AI Similarity Searching Import Inventory Locations by Unique Box Names:

article thumbnail

Startup Glycomine raises $115M to push rare disease drug deeper into testing

BioPharma Drive: Drug Pricing

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in glycosylation.

Disease 243
article thumbnail

CDC Denies Milwaukee's Request for Help on Lead in Schools

Drugs.com

MONDAY, April 14, 2025 -- When officials in Wisconsin's largest city asked the U.S. Centers for Disease Control and Prevention (CDC) for help dealing with high levels of lead in city schools, the answer wasn't what they expected. The CDC said no.

Disease 279
article thumbnail

Cosmic twist: The universe could be spinning

Science Daily: Pharmacology News

A new study suggests the universe may rotate -- just extremely slowly. The finding could help solve one of astronomy's biggest puzzles.

289
289
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

How to Ensure Compliance in Generic Drug Development

Drug Patent Watch

"Compliance in Generic Drug Development: A Critical Component of Success As the generic drug industry continues to grow, ensuring compliance with regulatory requirements has become a top priority for pharmaceutical companies. At DrugPatentWatch, we've seen firsthand the importance of staying on top of regulatory changes and maintaining a robust compliance program.

article thumbnail

CDC panel mulls changes to COVID shot recommendations

BioPharma Drive: Drug Pricing

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, also discussed the Texas measles outbreak.

234
234
article thumbnail

Heavy Weed Use Increases Risk Of Dementia

Drugs.com

WEDNESDAY, April 16, 2025 -- Middle-aged folks and seniors whose weed use lands them in the hospital are at higher risk for developing dementia within a matter of years, a new study says.An ER visit or hospitalization due to cannabis use is.

Hospitals 265
article thumbnail

Nurturing now, thriving later: The lasting power of affectionate mothering

Science Daily: Pharmacology News

Affectionate mothering in childhood may have a lasting impact on important personality traits, potentially influencing life outcomes such as educational achievement, economic success, and health and well-being, according to new research. The findings suggest that positive maternal parenting could foster important traits such as openness, conscientiousness and agreeableness.

Research 288
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Frameworks for Decision-Making & Lessons Learned from “Failing Fast”

LifeSciVC

By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC Drug discovery and development is a long, and often fraught, journey it typically takes more than a decade to progress from idea to approved drug, and less than 10% of drugs that enter the clinic succeed in achieving commercialization. Creating new drugs for patients is certainly not for the faint of heart.

article thumbnail

Bluebird says Ayrmid missed deadline for rival takeover bid

BioPharma Drive: Drug Pricing

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about $29 million upfront.

232
232
article thumbnail

First Weight-Loss Pill From Lilly, Orforglipron, Shows Promising Results

Drugs.com

FRIDAY, April 18, 2025 — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar.

Drugs 258
article thumbnail

Popular CT scans could account for 5% of all cancer cases a year, study suggests

Science Daily: Pharmacology News

CT scans may account for 5% of all cancers annually, according to a new study that cautions against overusing and overdosing CTs. The danger is greatest for infants, followed by children and adolescents. But adults also are at risk, since they are the most likely to get scans.

289
289
article thumbnail

Can Plants Really “See”?

Codon

In the early 2010s, Chilean plant ecologists Ernesto Gianoli and Fernando Currasco-Urra spotted what looked like a peculiar tree stem in the rainforest. On closer inspection, they realized it was a vine, Boquila trifoliolata , imitating a nearby tree’s leaves — closely matching their size, shape, and vein patterns. After further study, Gianoli and Carrasco-Urra discovered that this aptly named “Chameleon Vine” could mimic all sorts of plants, or even multiple different pl

article thumbnail

Makary seeks to limit industry’s role in FDA advisory panels

BioPharma Drive: Drug Pricing

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as industry representatives on advisory committees.

FDA 173
article thumbnail

FDA Announces Plan to Phase Out Some Animal Testing

Drugs.com

MONDAY, April 14, 2025 -- The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs, favoring more effective, human-relevant methods.The new strategy.

article thumbnail

A new record for California's highest tree

Science Daily: Pharmacology News

A professor's casual hike in the High Sierra turned into a new elevation record for California's highest tree, the Jeffrey pine, which wasn't formerly known to grow at extreme elevations.

281
281